A61P 33/08
For pneumocystis carinii
Official title: for Pneumocystis carinii
A61P33/08 (For pneumocystis carinii) appears on 114 US grants and 158 published applications in this corpus.
Search patents in A61P- Granted patents
- 114
- Published applications
- 158
- Assignees
- 62
- Inventors
- 276
- Latest grant
- 6 Mar 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 6 | 0 |
| 2001 | 9 | 2 |
| 2002 | 5 | 2 |
| 2003 | 7 | 10 |
| 2004 | 9 | 17 |
| 2005 | 3 | 9 |
| 2006 | 7 | 6 |
| 2007 | 3 | 5 |
| 2008 | 3 | 4 |
| 2009 | 6 | 7 |
| 2010 | 5 | 45 |
| 2011 | 6 | 10 |
| 2012 | 4 | 5 |
| 2013 | 7 | 7 |
| 2014 | 8 | 8 |
| 2015 | 4 | 5 |
| 2016 | 7 | 3 |
| 2017 | 1 | 4 |
| 2018 | 2 | 1 |
| 2019 | 0 | 4 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Substituted imidazoquinolines6 Mar 2018US 9,908,880 B24Sc AG
- Methods of treating androgen receptor-mediated disorders with imidazoline derivatives20 Feb 2018US 9,895,355 B2Jiangsu Hengrui Medicine Co., Ltd.
- Imidazoline derivatives, preparation methods thereof, and their applications in medicine7 Mar 2017US 9,586,947 B2Jiangsu Hengrui Medicine Co., Ltd.
- Substituted imidazoquinolines20 Sep 2016US 9,446,040 B24Sc AG
- IL-1 binding proteins20 Sep 2016US 9,447,183 B2AbbVie Inc.
- Chemical composition13 Jul 2023US 2023/0218547 A1The Johns Hopkins University
- IL-1 Binding Proteins13 Apr 2023US 2023/0112863 A1AbbVie Inc.
- Novel tricyclic compounds16 Mar 2023US 2023/0082167 A1AbbVie Inc.
- Boron-Containing Small Molecules11 Mar 2021US 2021/0070780 A1Anacor Pharmaceuticals, Inc.
- IL-1 Binding Proteins26 Dec 2019US 2019/0389945 A1AbbVie Inc.
Most cited
By later US patents
- Imidazonaphthyridines255US 6,194,425 B13M Innovative Properties Company · 2001
- Amide substituted imidazoquinolines237US 6,451,810 B13M Innovative Properties Company · 2002
- Urea substituted imidazoquinoline ethers167US 6,656,938 B23M Innovative Properties Company · 2003
- Sulfonamido ether substituted imidazoquinolines162US 6,683,088 B23M Innovative Properties Company · 2004
- Aryl ether substituted imidazoquinolines161US 6,670,372 B23M Innovative Properties Company · 2003